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Dissection of the Role of the Stable Signal Peptide of the Arenavirus
Envelope Glycoprotein in Membrane Fusion
Emily L. Messina,a,b Joanne York,a and Jack H. Nunberga
Montana Biotechnology Centera and Division of Biological Sciences,b The University of Montana, Missoula, Montana, USA
The arenavirus envelope glycoprotein (GPC) retains a stable signal peptide (SSP) as an essential subunit in the mature complex.
The 58-amino-acid residue SSP comprises two membrane-spanning hydrophobic regions separated by a short ectodomain loop
that interacts with the G2 fusion subunit to promote pH-dependent membrane fusion. Small-molecule compounds that target
this unique SSP-G2 interaction prevent arenavirus entry and infection. The interaction between SSP and G2 is sensitive to the
phylogenetic distance between New World (Junín) and Old World (Lassa) arenaviruses. For example, heterotypic GPC com-
plexes are unable to support virion entry. In this report, we demonstrate that the hybrid GPC complexes are properly assembled,
proteolytically cleaved, and transported to the cell surface but are specifically defective in their membrane fusion activity. Chi-
meric SSP constructs reveal that this incompatibility is localized to the first transmembrane segment of SSP (TM1). Genetic
changes in TM1 also affect sensitivity to small-molecule fusion inhibitors, generating resistance in some cases and inhibitor de-
pendence in others. Our studies suggest that interactions of SSP TM1 with the transmembrane domain of G2 may be important
for GPC-mediated membrane fusion and its inhibition.
Arenaviruses comprise a diverse family of enveloped negative-strand RNA viruses that are endemic to rodent populations
worldwide. Infection can be transmitted to humans to cause se-
vere acute hemorrhagic fevers with high morbidity and mortality.
Lassa fever virus (LASV) is prevalent in western Africa, infecting a
half-million persons annually (26). Five species of New World
(NW) hemorrhagic fever viruses are distributed throughout
South America, including the Junín virus (JUNV) in Argentina.
New arenavirus species frequently emerge from rodent reservoirs
(5, 9, 11). In the absence of effective vaccines or therapies, the
hemorrhagic fever arenaviruses are recognized to pose significant
threats to public health and biodefense. Accordingly, these viruses
are classified as Category A priority pathogens, and JUNV has
additionally been determined by the Department of Homeland
Security to pose a Material Threat to the U.S. population.
Arenavirus entry into the host cell is mediated by the virus
envelope glycoprotein (GPC) (Fig. 1). Upon binding to a cell sur-
face receptor (reviewed in references 10 and 29), the virion is
endocytosed, and GPC-mediated fusion of the viral and endo-
somal membranes is activated upon acidification in the maturing
endosome. GPC is synthesized as a precursor glycoprotein and
cleaved by the cellular SKI-1/S1P protease in the Golgi (22, 25) to
generate the receptor-binding (G1) and transmembrane fusion
(G2) subunits. The mature GPC complex is metastable and thus
primed to mediate membrane fusion in response to acidic pH.
Upon activation, GPC undergoes a series of conformational
changes leading to formation of a trimer-of-hairpins structure
(14, 20, 41) and fusion of the viral and cellular membranes (re-
viewed in references 19 and 39). The arenavirus GPC is unique
among class I envelope glycoproteins in that it retains its cleaved
signal peptide as a third subunit (13, 15, 47).
The 58-amino-acid stable signal peptide (SSP) of GPC con-
tains two hydrophobic segments that span the membrane and are
joined by a short ectodomain loop (Fig. 1) (2). The cytoplasmic N
terminus of SSP is myristoylated, while the penultimate C-termi-
nal cysteine (C57) coordinates with a zinc-binding domain in the
cytoplasmic tail of G2 to form an intersubunit structure that an-
chors SSP in the GPC complex (6, 43). SSP association masks
endogenous endoplasmic reticulum (ER) retention/retrieval sig-
nals in the cytoplasmic domain of G2 to facilitate GPC transport
through the Golgi (1), whereupon the precursor is proteolytically
cleaved and transported to the cell surface for virion assembly.
Our studies suggest that pH-induced activation of the mature
GPC complex is controlled by a unique interaction between the
short ectodomain loop of SSP and the G2 fusion subunit. Side
chain substitutions that reduce positive polarity at SSP K33 de-
press the pH required to trigger membrane fusion (46), and this
phenotype can be rescued by secondary mutations in G2 (45).
Importantly, this SSP-G2 interaction provides a molecular target
for small-molecule compounds that stabilize the prefusion GPC
complex, thereby preventing pH-induced activation in the endo-
some (4, 23, 24, 42). The different classes of fusion inhibitors
demonstrate distinct patterns of specificity against New World
(NW) and Old World (OW) arenaviruses yet share a binding site
on GPC (4, 23, 37, 42). Sequence variation at the nominal SSP-G2
interface likely accounts for the differences in species specificity
(37, 42). Several of these fusion inhibitors have recently been
shown to protect against lethal arenavirus disease in animal mod-
els (4, 8).
Sequence variation between OW and NW arenavirus species
may also affect the ability of one SSP to function in the context of
a heterotypic GPC complex. For instance, recombinant JUNV vi-
rions in which SSP and the G1G2 precursor are heterotypic are not
viable (3). We have exploited this interspecies incompatibility be-
tween LASV and JUNV GPCs to identify determinants in SSP
required for membrane fusion activity. We found that SSP asso-
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ciation, proteolytic maturation, and transport to the cell surface
are promiscuous in interspecific hybrid GPCs and that heterotypic
SSPs support these functions in the context of either JUNV or
LASV G1G2 precursors. Preservation of pH-dependent mem-
brane fusion, however, requires a specific homotypic match in the
first transmembrane domain (TM1) of SSP. We propose that this
amphipathic helical region of SSP interacts with the transmem-
brane domain of G2 and thus contributes to the pH-dependent
membrane fusion activity of arenavirus GPC.
MATERIALS AND METHODS
Plasmids. GPC from the pathogenic MC2 isolate of JUNV (17) and from
the Josiah isolate of LASV (23) was expressed using the minimal T7 pro-
moter sequence in pcDNA 3.1-based vectors (Life Technologies). In order
to obviate concerns regarding signal peptidase cleavage of SSP in the chi-
meric GPC constructs, SSP and G1G2 open reading frames were ex-
pressed from separate plasmids, taking advantage of the ability of the two
polypeptides to associate in trans to reconstitute the functional GPC com-
plex (12, 44). The G1G2 precursor was directed to the membrane using
the conventional signal peptide of human CD4, as previously described
(44). An innocuous FLAG affinity tag was appended to the C terminus of
LASV G1G2 to facilitate detection (47). SSP chimeras were constructed
using conventional PCR procedures, and mutations were introduced us-
ing QuikChange methodology (Stratagene).
Antibodies and small-molecule entry inhibitors. JUNV G1-specific
monoclonal antibodies (MAbs) BF11 and BE08 (33) were obtained
through the NIAID Biodefense and Emerging Infections Research Re-
sources Program (BEIResources) and the FLAG peptide-specific MAb
(M2) was purchased from Sigma. The LASV G1-specific MAb L52 134-23
(32) was kindly provided by Connie Schmaljohn (USAMRIID). The
small-molecule fusion inhibitors ST-294, ST-193, ST-161, and ST-761
have been previously described (4, 23, 37, 42) and were kindly provided by
SIGA Technologies (Corvallis, OR).
Analysis of GPC expression. GPC was expressed by transient trans-
fection in Vero cells infected with the vTF-7 vaccinia virus expressing T7
polymerase (16) or in engineered BHK-21 cells expressing T7 polymerase
(BSR T7/5) (7), kindly provided by Klaus Conzelmann (Ludwig-Maxi-
milians-University Munich). Proteins were metabolically labeled using
35S-labeled amino acids (Perkin Elmer) and immunoprecipitated with the
appropriate MAb as previously described (44). Flow cytometric detection
of cell surface GPC was hindered by low levels of expression using our
pcDNA-based vectors in BSR T7/5 cells, especially for LASV GPC (see
Results and Discussion). Therefore, for these studies GPC was expressed
in Vero cells using a pCAGGS-MCS vector (27) provided by Juan Carlos
de la Torre (Scripps Research Institute) (38). Cell surface expression was
determined using the JUNV G1-specific MAb BE08 (33) or the LASV
G1-specific MAb L52 134-23 (32), and a secondary fluorescein isothio-
cyanate (FITC)-labeled anti-mouse immunoglobulin antibody. The cell
populations were stained with propidium iodine to exclude dead cells,
fixed with 2% formaldehyde, and analyzed using a FACSCalibur flow
cytometer (BD Biosciences).
Analysis of GPC-dependent membrane fusion. The recombinant
vaccinia virus-based assay for GPC-mediated cell-cell fusion was per-
formed as previously described (46). Briefly, Vero cells infected by vTF-7
and expressing GPC are cocultured with cells infected with a recombinant
vaccinia virus vCB21R-lacZ bearing the -galactosidase gene under the
control of the T7 promoter (28). Cell-cell fusion is triggered by exposure
to medium adjusted to pH 5.0 and detected through -galactosidase ex-
pression in the newly formed syncytia. Fusion is quantitated by chemilu-
minescence using the GalactoLite Plus substrate (Life Technologies). Fu-
sion inhibition by small-molecule SIGA compounds was determined as
previously described (42) and GraphPad Prism software was used for
nonlinear regression calculations using a single-slope dose-response
model constrained to 100% fusion in the absence of inhibitor.
In order to circumvent biosafety concerns associated with the use of
vaccinia viruses, we developed an alternative fusion reporter assay based
on expression of T7 polymerase in BSR T7/5 cells. In this format, GPC-
expressing BSR T7/5 cells were cocultured with human 293T cells trans-
fected with the internal ribosome entry site (IRES)-containing pT7EMC-
luc reporter plasmid expressing luciferase under the control of the T7
promoter (34), which was kindly provided by Yoshiharu Matsuura
(Osaka University). Following a 5-min exposure to medium adjusted to
pH 5.0, the coculture was continued at neutral pH for 12 h to allow for
luciferase expression. Cell-cell fusion was detected using the luciferase
assay kit substrate (Promega). Consistency of GPC expression was mon-
itored by immunohistochemical staining. Results from this novel fusion
reporter assay were validated in parallel experiments using the well-estab-
lished vaccinia virus-based assay.
FIG 1 GPC open reading frame and subunit organization, and comparison of JUNV and LASV SSP amino acid sequences. (Top left) Amino acid residues are
numbered according to the sequences of JUNV GPC. The mature subunits (SSP, G1, and G2) are labeled, as are the signal peptidase (SPase) and SKI-1/S1P
cleavage sites. The myristoylation site at glycine-2 is labeled, and the transmembrane regions in SSP and G2 are shaded. The two heptad-repeat sequences in G2,
and the hinge-region disulfide-bonded loop, are drawn in black. (Bottom left) The amino acid sequences of JUNV and LASV SSP are compared. The two
hydrophobic membrane-spanning regions (h1 and h2) are shaded, and conserved residues referred to in the text are boxed (myristoylation motif, P12, E17,
K33, and C57). Asterisks below the sequences indicate helical folds predicted by the PROFsec algorithm as implemented by PredictProtein (reliability score, 7)
(31). (Right) Schematic model for the subunit organization of the tripartite GPC complex. SSP is shown spanning the membrane twice (2); the myristoylated N
terminus is presumed to be associated with the cytoplasmic face of the membrane, and the penultimate C-terminal C57 residue participates in a binuclear
zinc-finger motif in G2 (6, 43). The K33 position in the ectodomain of SSP modulates pH-dependent membrane fusion and sensitivity to small-molecule fusion
inhibitors (42). The two heptad-repeat regions in the G2 ectodomain are shown in black. The relative placement of the three transmembrane regions is arbitrary
and the drawing is not to scale.
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RESULTS AND DISCUSSION
Divergence between JUNV and LASV SSPs. A comparison of the
amino acid sequences of JUNV and LASV SSPs reveals a high
degree of sequence divergence, as well as an overall conservation
of sequence motifs (Fig. 1). The two hydrophobic domains (h1
and h2) in each are separated by a short region containing the
conserved K33 residue (46). A myristoylation motif and zinc-co-
ordinating cysteine (C57) are present in both N- and C-terminal
cytoplasmic domains, respectively (2). Both SSPs are also pre-
dicted to possess similar secondary structure features, with two
helical regions interspersed by an unstructured ectodomain loop.
Despite these similarities, fewer than 40% of the amino acids are
identically conserved.
Hybrid GPC containing heterologous SSP and G1G2. Re-
verse-genetics studies have shown that hybrid GPC complexes are
functional for arenavirus infection if and only if SSP is homotypic
with the TM and C-terminal cytoplasmic domains of G2 (3). To
investigate the molecular basis for this finding, we characterized
the assembly, transport, and function of hybrid GPCs. Taking
advantage of the observation that SSP can associate in trans with
the G1G2 precursor to reconstitute the functional GPC complex
(12, 47), we coexpressed JUNV or LASV SSP with the reciprocal
G1G2 precursors, which contained the conventional signal pep-
tide of human CD4 (44, 47).
Membrane fusion activity of the homologous and heterolo-
gous hybrid GPCs was determined using a biosafe modification of
the well-characterized vaccinia virus-based cell-cell fusion assay
(47). BSR T7/5 cells expressing the bacteriophage T7 polymerase
(7) were cotransfected with pcDNA3.1-based plasmids expressing
SSP and the G1G2 precursor under the control of the T7 pro-
moter. These cells were then cocultured with 293T fusion reporter
cells expressing luciferase in a T7 polymerase-dependent manner.
Cell-cell fusion was initiated by exposing the coculture to medium
adjusted to pH 5.0, and luciferase expression in the newly formed
syncytia was determined following continued incubation at neu-
tral pH. Using this assay, we verified that neither of the two het-
erotypic GPC hybrids (JUNV SSP with LASV G1G2 or LASV SSP
with JUNV G1G2) was able to mediate membrane fusion (Fig.
2A). Concordant cell-cell fusion results were obtained using the
vaccinia virus-based fusion reporter assay (reference 47 and data
not shown).
Hybrid GPC assembles and is transported to the cell surface.
To determine the molecular basis of heterotypic incompatibility,
we first investigated the ability of SSP to associate with the G1G2
precursor. It is possible that the absence of membrane fusion ac-
tivity reflects an inability of SSP to bind the heterologous G1G2
precursor, thereby preventing GPC transport through the Golgi,
proteolytic maturation, and cell surface expression. To assess GPC
biogenesis, SSP and the G1G2 precursor were expressed in trans,
and metabolically labeled GPC was immunoprecipitated (44) us-
ing MAbs directed to either JUNV G1 (33) or the C-terminal
FLAG tag on LASV G2. We found that GPC protein synthesis was
markedly reduced in BSR T7/5 cells relative to that typically seen
in Vero cells infected with recombinant vaccinia viruses express-
ing T7 polymerase (16, 47), presumably reflecting the absence of
mRNA capping in the cytosol of transfected BSR T7/5 cells. Nev-
ertheless, SDS-PAGE analysis showed that SSP association in the
heterotypic GPCs was similar to that in the homotypic complex
(Fig. 3A). Furthermore, this association was sufficient to promote
FIG 2 Membrane fusion activity of JUNV and LASV hybrids and TM1 mu-
tants. Schematic drawings of chimeric SSP constructs are shown to the right of
A and B. Regions 1, 2, and 3 (R1, R2, and R3, respectively) are boxed, and
JUNV or LASV sequences are indicated by black or white fills, respectively. The
regions are drawn to scale, and junction amino acid residues are labeled. Cell-
cell fusion by hybrid GPCs containing JUNV or LASV G1G2 and the SSP
chimeras is indicated by paired black and white bars, respectively, to the right.
Fusion activity was determined using BSR T7/5 cells (7) as described in Mate-
rials and Methods and normalized as a percentage of the respective wild-type
JUNV or LASV GPC. The symbol  is used to indicate the absence of signifi-
cant fusion. Error bars represent the standard error of the mean (SEM) of 2 to
6 independent assays. (C) Mutated JUNV SSPs were expressed with JUNV
G1G2 and cell-cell fusion was normalized to the wild type. One complete assay
representative of at least four experiments with complete or partial collections
of the mutants is depicted. Each point is an average of 8 duplicate wells, and
error bars (SEM) are shown. The bar denoting S27A cell-cell fusion (284% 
14%) is truncated at 200% of wild type.
Messina et al.
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a significant degree of proteolytic maturation of the heterologous
G1G2 precursor (Fig. 3A).
Flow cytometry was used to confirm trafficking of the hetero-
typic GPC hybrids to the cell surface. Due to the low level of
expression of LASV GPC in BSR T7/5 cells (Fig. 3A), we used a
well-characterized pCAGGS plasmid vector (27) for these studies
of GPC transport (38). Cell surface accumulation of heterologous
GPC hybrid was found to be similar to that of the homotypic
protein in both cases (Fig. 3B). As GPC transport does not require
proteolytic cleavage (1, 36), these findings assess an independent
function of SSP association. Conversely, transit of GPC through
the Golgi, as evidenced by proteolytic cleavage, is predictive of cell
surface expression. Despite substantial sequence divergence, both
heterologous SSPs were capable of promoting the assembly and
maturation of the hybrid GPC complex, as well as its transport to
the plasma membrane. This result agrees with previous studies
using a recombinant LASV GPC encoding JUNV SSP (3). Because
very low levels of mature GPC are sufficient to support membrane
fusion activity (2, 40), we surmise that the partial reductions in
SSP association and proteolytic cleavage in the heterotypic GPC
hybrids are by themselves insufficient to explain the complete loss
of fusogenicity. This conclusion is reinforced by the overall lack of
correlation between variations in proteolytic cleavage and mem-
brane fusion activity in studies using chimeric SSP molecules (see
below).
Interchange of the ectodomain loop in SSP. We have previ-
ously shown that the short ectodomain loop of SSP is critical for
pH-dependent membrane fusion and its inhibition by small-mol-
ecule inhibitors (42, 46). This region of JUNV SSP is defined by
charged residues at the ectodomain termini of TM1 and TM2
(K33 and K40, respectively) (Fig. 1). We therefore subdivided SSP
into three regions for purposes of constructing chimeras: region 1
included the myristoylated N terminus of SSP and TM1 (residues
M1 to K33), region 2 comprised the ectodomain loop (K33 to K40
in JUNV, T40 in LASV), and region 3 contained TM2 and the
short cytoplasmic domain bearing C57 (to the C-terminal T58).
All combinations of the three JUNV and LASV subdomains were
constructed (Fig. 2A), and the chimeric SSPs were named accord-
ing to the three regions. For instance, JJJ represents the wild-type
JUNV SSP and JLJ signifies a chimera in which the ectodomain
from LASV was fused to regions 1 and 3 of JUNV SSP. For clarity,
we will refer to recombinant SSPs as chimeras and reserve the term
hybrid for the reconstituted GPC complex.
As anticipated from the fully heterotypic GPC hybrids (Fig.
3A), all of the chimeric SSPs associated with the JUNV G1G2
precursor and supported proteolytic cleavage in BSR T7/5 cells
FIG 3 JUNV and LASV hybrid GPCs are properly assembled, proteolytically matured, and transported to the cell surface. Combinations of JUNV and LASV
SSPs and G1G2 precursor proteins were coexpressed in BSR T7/5 cells, and the metabolically labeled GPCs were immunoprecipitated for SDS-PAGE analysis
(46). GPCs containing JUNV G1G2 were precipitated using the G1-directed MAb BF11 (33), and those containing LASV were collected using a FLAG tag
appended to the C terminus of G1G2. (A) The immunoprecipitated proteins were resolved using a 4 –12% NuPAGE Bis-Tris gel (Invitrogen). The JUNV and
LASV G1G2 precursors and coprecipitated SSPs are indicated. The mature G1 and G2 glycoproteins are heterodisperse and are better resolved as polypeptides
following deglycosylation using PNGaseF (New England BioLabs) (bottom). The unequal recovery of G1 and G2 subunits seen in some experiments using
G1-directed (JUNV) or G2-directed FLAG (LASV) antibodies likely reflects partial dissociation of the complex during immunoprecipitation. While GPC
expression in BSR T7/5 cells is adequate for membrane fusion activity, protein levels are low, and carets are used to distinguish background bands manifest in
mock-transfected cells. (B) Cell surface accumulation of JUNV and LASV GPC hybrids expressed in Vero cells using a pCAGGS plasmid (27, 38) was determined
by flow cytometry. GPC was detected using JUNV or LASV G1-specific MAbs (BE08 [33] or L52 134-23 [32], respectively) and a FITC-conjugated secondary
antibody. Cells expressing JUNV SSP (thin line) or LASV SSP (thick line) are compared with those in which the cell surface transport of the respective G1G2
precursor is prevented by the absence of SSP (shaded histogram) (1).
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(Fig. 4). Parallel metabolic labeling studies using LASV GPC again
showed poor expression but nonetheless allowed similar conclu-
sions (not shown). These findings were further validated using
recombinant vaccinia virus to drive GPC expression (reference 47
and data not shown). We conclude that the sequence require-
ments for SSP association and proteolytic maturation are rela-
tively relaxed in interspecific GPC chimeras.
Despite its critical role in membrane fusion, interspecific ex-
change of the ectodomain loop had little effect on the fusion ac-
tivity of hybrid GPCs (Fig. 2A). LJL did not restore fusion activity
to the JUNV G1G2 hybrid (3% of wild-type JUNV GPC) and
likewise the reciprocal JLJ SSP in the LASV G1G2 hybrid (1% of
wild-type LASV GPC). Conversely, replacement of the ectodo-
main in JUNV SSP with that of LASV (JLJ) had a relatively small
effect on the fusion activity of the hybrid JUNV GPC (40% of
JUNV GPC). The reciprocal hybrid, LASV G1G2 bearing LJL SSP,
retained a lower albeit significant level of activity (10% of LASV
GPC). We conclude that a homotypic ectodomain loop in SSP is
neither sufficient nor absolutely necessary to support membrane
fusion by the hybrid GPC complex.
Region 1 of SSP is essential for membrane fusion activity.
Analysis of the remaining SSP chimeras did reveal an important
role for the N-terminal region 1 in SSP function. Only LASV hy-
brids containing the homologous region 1 (LJL, LLJ, and LJJ)
showed significant membrane fusion activity (Fig. 2A). Whereas
the LJL hybrid supported 10% of wild-type activity (above), the
latter two SSP chimeras promoted cell-cell fusion at levels compa-
rable to those of native LASV GPC. The reciprocal pattern was
seen with the JUNV G1G2 precursor and the JLJ, JJL, and JLL
chimeras. In JUNV GPC, SSP bearing a mismatch in regions 1 and
2 (LLJ) unexpectedly also exhibited fusion activity (20% of the
wild type). By comparison, all hybrids displayed similar patterns
of GPC expression (Fig. 4). Taken together, these results indicate
that homotypic pairing in SSP region 1 is paramount for mem-
brane fusion activity. Region 2 appears to contribute somewhat to
activity when the homologous region 1 is present (JJL and LLJ),
whereas homology in region 3 is relatively unimportant. The re-
ciprocal relationship between JUNV and LASV hybrids validates
the importance of region 1 as a determinant of GPC-mediated
membrane fusion.
The apparent indifference to sequence variation in region 3 is
consistent with previous results from mutational studies (2). Trip-
let alanine replacements in TM2 of JUNV SSP (44FQF46 and
47FVF49 mutants) have no affect on fusogenicity. Similarly in the
short C-terminal cytoplasmic tail of SSP, only the conserved C57
side chain is essential for membrane fusion activity (44). Collec-
tively, these observations suggest a lack of sequence specificity in
the function of region 3. However, the presumed helical nature of
TM2 appears to be important, as SSP association is completely
abrogated by single amino acid deletions that are expected to alter
the register of the helix (2).
TM1 forms an extended helical domain. To further dissect the
role of region 1 in fusogenicity, we bisected the N-terminal cyto-
plasmic and TM regions using the conserved E17 as the nominal
cytosolic junction of TM1. Thus, the (J1L2) exchange in region 1
comprised JUNV residues M1 to E17 and LASV residues E17 to
K33 (Fig. 2B). SSPs including the reciprocally exchanged se-
quences (J1L2 and L1J2) associated with and supported proteo-
lytic maturation of both JUNV (Fig. 4) and LASV precursors (not
shown) but were entirely defective in promoting membrane fu-
sion (Fig. 2B). In contrast, the parental SSP chimeras containing
the intact region 1 (JJL and LJL) produced functional hybrids with
their respective G1G2 precursors. The symmetric loss of fusoge-
nicity at this junction is likely to reflect an internal sequence in-
compatibility within the SSP chimeras rather than between SSP
and G2.
Secondary structure predictions suggested a possible explana-
tion for this intramolecular incompatibility (Fig. 1). For both
JUNV and LASV SSP, prediction algorithms (30) suggest that the
helical structure of TM1 extends N terminally to the conserved
proline at position 12. To test this notion, we generated additional
region 1 exchanges in which TM1 was extended N terminally to
P12. We found that an SSP chimera including the extreme N-ter-
minal residues of LASV (residues M1 to P12) and the extended
helical region of JUNV (residues P12 to K33), referred to as
(LexJ)JL, supported cell-cell fusion comparably to the parental JJL
chimera in the hybrid JUNV GPC (Fig. 2B). Likewise, SSPs con-
taining the (JexL)LJ and (JexL)JL exchanges promoted detectable
fusion activity in LASV G1G2 hybrids. In keeping with our previ-
ous finding that replacing E17 with alanine did not disrupt mem-
brane fusion activity (46), we propose that TM1 spans P12 to K33
to form a functional transmembrane subdomain in SSP.
The above results also suggest that the extreme N terminus of
SSP, comprising a myristoylation motif (GxxxS/T) and residues
through I11, is interchangeable between JUNV and LASV. Indeed,
alanine-scanning mutagenesis in this region of LCMV SSP
showed only minimal effects on fusogenicity (35). The amino acid
sequence of the cytoplasmic portion of region 1 appears relatively
unimportant for membrane fusion activity. By contrast, the lack
of myristoylation in SSP reduces fusogenicity by 80% through
an unknown mechanism (35, 47).
Genetic analysis of the extended TM1. Site-directed mutagen-
FIG 4 JUNV GPCs containing chimeric SSPs are properly assembled and
proteolytically matured. JUNV G1G2 was coexpressed with the indicated chi-
meric SSPs in BSR T7/5 cells, and metabolically labeled GPC was immunopre-
cipitated for SDS-PAGE analysis as described in Fig. 3. The G1G2 precursors
and coprecipitated SSPs are indicated (top). The mature G1 and G2 glycopro-
teins are heterodisperse and are better resolved as polypeptides following
deglycosylation using PNGaseF (New England BioLabs) (bottom).
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esis was used to probe the extended TM1 helix in JUNV SSP. We
reasoned that deletion of a single amino acid residue would alter
the register of the helix without disrupting the overall helical fold
(2). A JUNV GPC mutant bearing a deletion at TM1 residue A25
was found to be devoid of membrane fusion activity (Fig. 2C),
consistent with a requirement for specific interhelical interactions
within the GPC complex. Replacing hydrophobic amino acids
with arginines in a membrane-spanning region is expected to be
highly destabilizing, and the F14R and A25R mutants were indeed
defective in membrane fusion (Fig. 2C). The deficiency in F14R
supports our previous suggestion that SSP enters the membrane at
P12. Neither the deletion nor arginine replacement mutants asso-
ciated with the G1G2 precursor (not shown). Taken together,
these results point to the critical importance of the extended TM1
helix in GPC biology.
Owing to the helix-breaking property of proline, TM1 is un-
likely to include residues N terminal to the conserved P12. To
determine whether P12 itself is essential for GPC assembly and
fusogenicity, we mutated this position in JUNV SSP to alanine.
The P12A mutant was found to possess wild-type fusion activity
(Fig. 2C). The identical mutant in LCMV SSP also showed signif-
icant fusion activity (30% of the wild type) but did not promote
entry by recombinant virus-like particles (35). Thus, a proline-
dependent articulation between the cytosolic N terminus and
TM1 is not required for fusogenicity per se.
TM1 forms an amphipathic helix. A helical-wheel projection
diagram reveals distinct hydrophobic and hydrophilic faces to the
extended TM1 helices in JUNV and LASV SSPs (Fig. 5). By con-
trast, TM2 of SSP (K40/T40 to G54) is uniformly hydrophobic. As
TM2 was found to be highly tolerant of triplet-alanine substitu-
tions (2), we employed a similar strategy to examine the require-
ment for side chain-specific interactions in TM1. We replaced
three hydrophobic sequences in TM1 of JUNV SSP (13TFL15,
22ALV24, and 29IAI31) with triplet alanines, a small residue with
high helical propensity. Alanine substitutions at 13TFL15 and
22ALV24 were found to disrupt membrane fusion activity (Fig.
2C). Fusogenicity was unaffected by alanine replacements at
29IAI31, probably due to its position in the helix and the conser-
vative nature of the change. The defect in the 13TFL15 and
22ALV24 mutants strongly suggests that TM1 participates in side
chain-specific interactions in the GPC complex, likely with the
transmembrane helical domain of G2.
To probe the contributions of specific side chains in TM1 to
these interactions, we individually replaced each polar residue on
the hydrophilic face of TM1 with alanine (Fig. 2C). T13A, Q16A,
and S27A GPCs were essentially wild type in cell-cell fusion activ-
ity, as was E17A (2). The N20A mutation, however, decreased
membrane fusion activity to 30% of the wild type (Fig. 2C), as
did the identical mutant in LCMV GPC (35). Interestingly, struc-
tural predictions by the Robetta server (http://robetta.bakerlab
.org) (21) consistently position N20 at a kink in the TM1 helix
(not shown).
SSP chimeras differ in sensitivity to small-molecule fusion
inhibitors. We have previously shown that both pH-dependent
activation and its inhibition by small-molecule fusion inhibitors
are mediated through interactions between SSP and the G2 fusion
subunit (42, 45, 46). We therefore examined the sensitivity of
hybrid GPCs to inhibition by the four chemically distinct fusion
inhibitors discovered by SIGA Technologies (Corvallis, OR) (4,
23, 37, 42). These compounds share a binding site (37) but differ
in their specificity toward NW and OW arenaviruses: ST-294 and
ST-761 are active only against NW viruses, ST-161 is specific for
LASV, and ST-193 is broadly inhibitory against both OW and NW
arenaviruses (4, 23, 37, 42).
As hybrid GPCs heterotypic in SSP region 1 are nonfunctional,
we focused our attention on the ectodomain loop, a region previ-
ously shown to affect inhibition (42). Substitution of the JUNV
ectodomain loop in LASV GPCs [LJJ and (JexL)JL] abrogated
inhibition by the LASV-active compounds ST-161 and ST-193
(not shown). In contrast, replacement of the ectodomain loop in
JUNV GPCs (JLL, JLJ) showed no significant effects on sensitivity;
all were inhibited by ST-294, ST-761, and ST-193 and resistant to
ST-161 (not shown). Structural differences at the hybrid inhibi-
tor-binding site likely contribute to the differing contributions of
the heterotypic SSP ectodomain in LASV and JUNV GPC. None
of the hybrids displayed de novo sensitivity to inhibition.
We utilized the panel of alanine mutations in JUNV TM1 to
further identify specific side chains that may influence sensitivity
to inhibition. The triplet-alanine mutant (the 29IAI31 mutant),
with substitutions adjacent to the SSP ectodomain and the critical
K33 residue, was found to be unchanged in its sensitivity to ST-
294 and ST-193 and resistance to ST-161 (Fig. 6 and Table 1).
Similarly, individual alanine mutations at Q16, E17, and S27 on
the hydrophilic face of TM1 did not significantly alter the pattern
of inhibition. By contrast, alanine substitutions toward the cyto-
solic terminus of TM1 (P12A and T13A) engendered resistance to
ST-193 without qualitative or quantitative changes in the effects of
ST-294, ST-761, or ST-161 (Fig. 6 and Table 1). Furthermore, the
N20A mutant was now strikingly dependent on ST-193 for wild-
type fusion activity. Fusion was enhanced by the addition of ST-
193 in a dose-dependent manner. Maximal activity approaches
that of the wild-type JUNV GPC at 10 M ST-193, at which
point inhibitory and/or cytotoxic effects may intervene. Sensitiv-
ities to ST-294 and ST-161 remain unaffected. The diversity in the
effects of these different amino acid substitutions highlights the
multiplicity of determinants for fusion inhibition within the GPC
complex (42, 45).
We suggest that ST-193 binding to N20A compensates for
structural changes induced by the mutation, thereby facilitating
on-path conformational changes during pH-induced activation
FIG 5 Helical-wheel projections of the amphipathic TM1 of JUNV and LASV
SSP. The drawing was prepared using DrawCoil 1.0 (18). This view is from the
N terminus of TM1 (P12) and extends through K33 in the SSP ectodomain.
Polar residues are highlighted in gray.
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of membrane fusion. Mutations in G2 previously reported to in-
crease the pH of activation in the K33Q mutant to wild type with-
out themselves affecting pH sensitivity may act similarly (45).
Among these compensatory G2 mutations, two (D400A and
F427A) also engender resistance to ST-193 and ST-294 (reference
42 and J.Y. and J.H.N., unpublished data). Based on the depen-
dence of the N20A mutant on the presence of inhibitor, we infer
that resistance at the two G2 positions, as well as that in P12A and
T13A SSP mutants, may reflect a balance of inhibitory and com-
pensatory consequences of ST-193 binding rather than a simple
loss in binding affinity.
Conclusions. Our previous studies have shown that the short
ectodomain loop of SSP and its interactions with G2 are impor-
tant determinants for both pH-dependent membrane fusion and
its inhibition by small-molecule compounds (42, 46). The present
study identifies the critical role of the first membrane-spanning
domain of SSP in these events. By characterizing a series of SSP
chimeras containing JUNV and LASV sequences, we demonstrate
that a homotypic pairing between TM1 and G2 is required for
GPC-mediated membrane fusion. We propose that multiple in-
tersubunit contacts between these transmembrane helices serve to
position the critical K33 side chain in the SSP ectodomain for
pH-sensitive interactions with the G2 ectodomain. Small-mole-
cule compounds that stabilize these interactions in the prefusion
GPC complex have been shown to prevent pH-induced fusion
activation in the endosome and thereby inhibit arenavirus entry.
Detailed knowledge of the atomic interactions between SSP and
G2 in the membrane-anchored GPC trimer will be important for
understanding the mechanism of pH-dependent membrane fu-
sion and guiding the design of potent and broadly active small-
molecule fusion inhibitors.
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